Alvotech Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Alvotech, a foreign private issuer based in Luxembourg, on February 27, 2026. The report discloses a specific transaction involving managers and closely associated persons as required by the Luxembourg Commission de Surveillance du Secteur Financier (CSSF).
Key Financial Metrics
The filing does not provide financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed is the transaction price of USD 4.74 per share for the share transfer described below.
Material Changes
On January 30, 2026, a transfer of 2,701,617 shares of Alvotech occurred between two entities within the Aztiq group:
- Seller: ATP Holdings ehf. (announced sale of 2,701,617 shares).
- Buyer: Aztiq Pharma Partners S.à r.l. ("Aztiq") (announced acquisition of 2,701,617 shares).
- Transaction Price: USD 4.74 per share.
- Nature of Transaction: An internal transfer of shares within the Aztiq group; ATP Holdings ehf. belongs to the Aztiq group.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It is strictly a regulatory disclosure of the share transaction.
Key Facts for Investor Verification
- Verify the total share ownership of Aztiq Pharma Partners S.à r.l. and ATP Holdings ehf. following this internal transfer.
- Confirm the current market price of Alvotech shares relative to the disclosed transaction price of USD 4.74.
- Note that this transaction did not result in a change of beneficial ownership outside the Aztiq group.